SCHEMBL8701992

SCHEMBL8701992

C(C=Cc1ccccc1)=CCCOCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.47
TSHR P16473 1/20 0.45
LMNA P02545 2/20 0.41
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40
CDK4 P11802 1/20 0.40
CCNB1 P14635 1/20 0.40
CCND1 P24385 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
PPARG P37231 1/20 0.39
LCK P06239 1/20 0.39
IDO1 P14902 3/20 0.38
ALOX5 P09917 2/20 0.38
NAAA Q02083 1/20 0.37
AGXT P21549 1/20 0.37
TRPA1 O75762 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
AKR1B10 O60218 1/20 0.36
AKR1B1 P15121 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8701990 1.00 MAOB (0.47) MAOBTSHRLMNACCNB2CDK1
SCHEMBL4372992 0.88 MAOB (0.56) MAOBLMNAIDO1ALOX5TRPA1
SCHEMBL31390334 0.79 TSHR (0.48) TSHRIDO1NAAAAGXTALDH1A1
SCHEMBL10776841 0.78 TSHR (0.47) TSHRLMNAPPARGLCKIDO1
SCHEMBL10776843 0.78 TSHR (0.47) TSHRLMNAPPARGLCKIDO1
SCHEMBL28722781 0.77 MAOB (0.56) MAOBLMNAALOX5TRPA1ALDH1A1
SCHEMBL16057177 0.76 TP53 (0.42) TSHRLCKALOX5AKR1B10AKR1B1
SCHEMBL17556990 0.76 TP53 (0.42) TSHRLCKALOX5AKR1B10AKR1B1
SCHEMBL16057178 0.76 TP53 (0.42) TSHRLCKALOX5AKR1B10AKR1B1
SCHEMBL22534824 0.76 L3MBTL1 (0.50) TSHRIDO1NAAAAGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed